Analysts at DNB Carnegie believe that Raysearch's stock price decline after the quarterly report was exaggerated, despite the stock falling by 15 percent. #Raysearch #aktier #strålterapi (translated)
Truecaller and Raysearch have suffered significant declines on the Stockholm Stock Exchange, while other companies such as Kabe and NCC have increased in value. #Börs #Truecaller #Raysearch (translated)
Raysearch's VD Johan Löf points out that the market is missing the company's long-term strategic perspective in an interview. #Raysearch #VDintervju #Långsiktighet (translated)
Raysearch reports a record revenue of 394 million kronor for the third quarter of 2026, an increase of 19 percent compared to the previous year. #Raysearch #medicinteknik #finansnyheter (translated)
Raysearch shares are under pressure with high short selling and great expectations ahead of the third quarter 2026 report, which could lead to price chaos. #Raysearch #aktier #finans (translated)
Martin Rex discusses the latest updates in the investigation regarding the insider scandal involving Raysearch in a segment on Börsmorgon. #Raysearchhärvan #Börsmorgon #Insiderhärvan (translated)
It progresses disturbingly easily. Sold Raysearch, Swedencare, and Coffee. Egetis has been added to the swing bag. Otherwise, continued Irlab and Vicore as applicable. Hopefully, important triggers will play out during Q4 in Irlab (deal) and Vicore (futility analysis). I have written enough about Egetis yesterday and today. But if someone had told me six months ago that I would be able to buy it below 9 SEK after FDA approval, I would have immediately called the mental health hotline and asked them to pick up the person in question. But that’s sometimes how it is on the stock market; opportunities arise when you least expect it. Act accordingly. Keeping my fingers crossed for a nice ending to the year! #Aktier #Investering #Finans (translated)
